Skip to main content

Table 1 Characteristics of exenatide once weekly studies

From: Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes

Author

N

Study duration (weeks)

Baseline A1C (%) a

Change in A1C (%) a,b

Baseline body weight (kg) a

Change in body weight (kg) a,b

Drucker et al. 2008 [14]

148

30

8.3

−1.9

102

−3.7

(DURATION-1)

Bergenstal et al. 2010 [9]

160

26

8.6

−1.5

89

−2.3

(DURATION-2)

Diamant et al. 2010 [13]

233

26

8.3

−1.5

91.2

−2.6

(DURATION-3)

Russell-Jones et al. 2012 [16]

248

26

8.5

−1.5

87.5

−2.0

(DURATION-4)

Blevins et al. 2011 [10]

129

24

8.5

−1.6

97.0

−2.3

(DURATION-5)

Buse et al. 2013 [11]

461

26

8.5

−1.3

90.9

−2.7

(DURATION-6)

Davies et al. 2013 [12]

111

26

8.4

−1.3

96.7

−2.7

Ji et al. 2013 [15]

340

26

8.7

−1.4

69.6

−1.6

  1. A1C: glycated hemoglobin; aAll mean or least-squares mean values; bAt study end point.